Company Summary
Search
Home Page
 
Quest PharmaTech Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
January 31TradingN
Board of Directors
NamePosition
Ian McConnan  Director of the Board
Lorne T. Meikle  Director of the Board
Not Applicable (None)  President
Paul Van Damme  Director of the Board
Ragupathy Madiyalakan  Director of the Board
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
16/Dec/1996  Canada Alberta ALBERTA - 12/16/96 
Exchange Filing Office
Location
Calgary Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Research and Development of Pharmaceutical Products  (not available) 
Securities
SymbolSecurity NameMarketStatus
QPTQuest Pharmatech Inc.TSX VentureTRADING
Name HistoryFromTo
Quest PharmaTech Inc.5/Oct/2005Present
Company Facts Reconciliation
SubjectDate Returned
Summer 2013 CFRNot Received
Associations
Auditing Firm:  Ernst & Young, Chartered Accountants
Law Firm:  Miller Thomson LLP
Subsidiary:  Steroidogenesis Inhibitors Canada Inc.
  Sonolight Pharmaceuticals Corp.
  Danamedix Inc.
  Altachem Pharma Inc.
Transfer Agent:  Computershare Trust Company of Canada
Latest Information
TypeDateTitle
News Releases  9/Jun/2014  NEWS RELEASE - QUEST PHARMATECH COMPLETES PATIENT ENROLLMENT IN PHASE IIB STUDY OF OREGOVOMAB FOR THE IMMUNOTHERAPY OF OVARIAN CANCER[CANADA NEWSWIRE]
    NEWS RELEASE - QUEST PHARMATECH ANNOUNCES THIRD COMBINATORIAL IMMUNOTHERAPY CLINICAL TRIAL FOR OREGOVOMAB WITH A TLR3 AGONIST HILTONOL®[CANADA NEWSWIRE]
    NEWS RELEASE - PRIVATE PLACEMENT NON BROKERED[MARKET NEWS]
Bulletins  23/Jan/2014  PP-N-B
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data